Test for covid 19
Materia Nova participated in the setting up, management and operation of the UMONS-led screening platform (SARS-CoV2 using RT-qPCR technology).
This first screening platform in Hainaut has been operational since the beginning of the epidemic for the benefit of the region's hospitals, their inpatients and their staff.
- Responsiveness to requests and speed of implementation.
- Expertise in the development of customized tests to evaluate the effectiveness of an antiviral surface treatment (SARS-CoV2...).
- Expertise in the development of disinfection strategies (plasma on surgical masks) and adapted efficiency tests.
- Participation in the validation of the kit based on antibodies (covid19) developed by the Mons company D-tek.